Granahan Investment Management, LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1026710 WALTHAM, MA

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$46,538,246

+$41,713,704 QoQ

Shares Held

147,231

+509.3% QoQ

Ownership

0.739%

of shares outstanding

% of Portfolio

1.66%

of 13F equity value

Holder Rank

#34

of 413 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 80% Shared 0% None 20%

Healthcare · as of Jun 30, 2026

Granahan Investment Management, LLC holds $227,093,647 across 25 Biotechnology names. LGND ranks #1 (20.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc This page	147,231	$46,538,246
2	CELC	Celcuity Inc.	179,053	$18,732,524
3	STOK	Stoke Therapeutics, Inc.	461,608	$15,103,813
4	SNDX	Syndax Pharmaceuticals Inc	446,988	$9,771,157
5	RYTM	Rhythm Pharmaceuticals, Inc.	83,270	$9,245,468
6	SRRK	Scholar Rock Holding Corp	163,759	$9,006,745
7	TSHA	Taysha Gene Therapies, Inc.	1,305,177	$8,888,255
8	ZYME	Zymeworks Inc.	336,157	$8,787,143

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$46,538,246	147,231	+509.3%	Shares	Sole	2026-08-14
2026-03-31	$4,824,542	24,165	-7.2%	Shares	Sole	2026-05-15
2025-12-31	$4,925,273	26,050	+4.4%	Shares	Sole	2026-02-17
2025-09-30	$4,421,768	24,962	+175.4%	Shares	Sole	2025-11-14
2022-03-31	$1,019,497	9,063	-86.9%	Shares	Sole	2022-05-16
2021-12-31	$10,679,515	69,141	-40.9%	Shares	Sole	2022-02-14
2021-09-30	$16,305,030	117,033	-28.0%	Shares	Sole	2021-11-15
2021-06-30	$21,326,902	162,565	-35.1%	Shares	Sole	2021-08-16
2021-03-31	$38,178,955	250,436	+29.5%	Shares	Sole	2021-05-17
2020-12-31	$19,227,555	193,339	+120.1%	Shares	Sole	2021-02-12
2020-09-30	$8,371,287	87,823	+87.3%	Shares	Sole	2020-11-12
2020-06-30	$5,243,302	46,878	-7.2%	Shares	Sole	2020-08-14
2020-03-31	$3,673,374	50,514	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.